The invention provides 3-arylethynyl substituted quinazolinone compounds of formula A as potential anticancer agents against sixty human cancer cell lines.
Filing Date: 15-02-2011
Issue Date: 16-08-2018
Applicant: CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad